Safety and efficacy are key cornerstones in the design and support of the LibreView system. Newyu takes its responsibilities as a medical device manufacturer seriously.
LibreView includes the LibreView website and LibreLinkUp mobile app.
LibreView is intended for use by patients, caregivers and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management.
In other words:
LibreView is a secondary viewer and is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
LibreView is not intended to be used for immediate clinical decision making, and is not intended to replace self-monitoring practices as advised by a physician.
Home users should consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software.
Healthcare professionals should use information in the software in conjunction with other clinical information available to them.
When using the LibreLinkUp mobile app:
LibreLinkUp is not intended to be used by clinicians.
Patients should not rely on caregivers to notify them about low or high glucose.
Dosing decisions should not be made based on this device. The user should follow instructions on the continuous glucose monitoring system.
Any problems with the mobile device, NFC, Bluetooth, wireless internet connection, mobile data connection, FreeStyle LibreLink, LibreLinkUp or LibreView could cause data to not be shared with caregivers, or delay transmission to caregivers.
LibreView (and thus LibreLinkUp) should be used only to give a secondary level of awareness and should not be expected to always communicate and transfer sensor glucose information.